Radioprotectants

Basic concepts, current status and future directions

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Uncontrolled exposure to radiation from possible nuclear battlefields, outer space travel or accidents at nuclear power plants presents the greatest threat and challenge to the civilized world today. The consequences of ionizing radiation, either from intentional or unintentional sources, on cells and tissues are complex phenomena. Death from radiation exposure is the result of sequences of events which occur within a fraction of a second to several weeks. One of the most challenging tasks of radiobiology today is the development of pharmacological agents that can protect, repair and regenerate the early damage produced in cells and tissues by ionizing radiation. Protection depends on the ability of chemical agents to reduce the intracellular concentration of free radicals and reactive oxygen species that are produced within the first millisecond after irradiation. The first-generation chemical agents used as radioprotectants are compounds with antioxidant and scavenging potential. Various novel compounds are currently under clinical investigation as radioprotectants that can accelerate recovery of tissue stem cells and their precursors after radiation exposure. Current treatment strategies also include the use of immunomodulators and natural products with free radical-scavenging capability and the ability to induce bone morrow recovery.

Original languageEnglish
Pages (from-to)681-689
Number of pages9
JournalDrugs of the Future
Volume33
Issue number8
DOIs
StatePublished - Aug 2008

Fingerprint

Ionizing Radiation
Free Radicals
Radiobiology
Nuclear Power Plants
Immunologic Factors
Biological Products
Accidents
Reactive Oxygen Species
Stem Cells
Antioxidants
Pharmacology
Bone and Bones
Radiation Exposure
Direction compound

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology

Cite this

Radioprotectants : Basic concepts, current status and future directions. / Singh, Somnath; Dash, Alekha K.

In: Drugs of the Future, Vol. 33, No. 8, 08.2008, p. 681-689.

Research output: Contribution to journalReview article

@article{5506b6e674a94975ac9b98a2b31a1876,
title = "Radioprotectants: Basic concepts, current status and future directions",
abstract = "Uncontrolled exposure to radiation from possible nuclear battlefields, outer space travel or accidents at nuclear power plants presents the greatest threat and challenge to the civilized world today. The consequences of ionizing radiation, either from intentional or unintentional sources, on cells and tissues are complex phenomena. Death from radiation exposure is the result of sequences of events which occur within a fraction of a second to several weeks. One of the most challenging tasks of radiobiology today is the development of pharmacological agents that can protect, repair and regenerate the early damage produced in cells and tissues by ionizing radiation. Protection depends on the ability of chemical agents to reduce the intracellular concentration of free radicals and reactive oxygen species that are produced within the first millisecond after irradiation. The first-generation chemical agents used as radioprotectants are compounds with antioxidant and scavenging potential. Various novel compounds are currently under clinical investigation as radioprotectants that can accelerate recovery of tissue stem cells and their precursors after radiation exposure. Current treatment strategies also include the use of immunomodulators and natural products with free radical-scavenging capability and the ability to induce bone morrow recovery.",
author = "Somnath Singh and Dash, {Alekha K.}",
year = "2008",
month = "8",
doi = "10.1358/dof.2008.033.08.1231875",
language = "English",
volume = "33",
pages = "681--689",
journal = "Drugs of the Future",
issn = "0377-8282",
publisher = "Prous Science",
number = "8",

}

TY - JOUR

T1 - Radioprotectants

T2 - Basic concepts, current status and future directions

AU - Singh, Somnath

AU - Dash, Alekha K.

PY - 2008/8

Y1 - 2008/8

N2 - Uncontrolled exposure to radiation from possible nuclear battlefields, outer space travel or accidents at nuclear power plants presents the greatest threat and challenge to the civilized world today. The consequences of ionizing radiation, either from intentional or unintentional sources, on cells and tissues are complex phenomena. Death from radiation exposure is the result of sequences of events which occur within a fraction of a second to several weeks. One of the most challenging tasks of radiobiology today is the development of pharmacological agents that can protect, repair and regenerate the early damage produced in cells and tissues by ionizing radiation. Protection depends on the ability of chemical agents to reduce the intracellular concentration of free radicals and reactive oxygen species that are produced within the first millisecond after irradiation. The first-generation chemical agents used as radioprotectants are compounds with antioxidant and scavenging potential. Various novel compounds are currently under clinical investigation as radioprotectants that can accelerate recovery of tissue stem cells and their precursors after radiation exposure. Current treatment strategies also include the use of immunomodulators and natural products with free radical-scavenging capability and the ability to induce bone morrow recovery.

AB - Uncontrolled exposure to radiation from possible nuclear battlefields, outer space travel or accidents at nuclear power plants presents the greatest threat and challenge to the civilized world today. The consequences of ionizing radiation, either from intentional or unintentional sources, on cells and tissues are complex phenomena. Death from radiation exposure is the result of sequences of events which occur within a fraction of a second to several weeks. One of the most challenging tasks of radiobiology today is the development of pharmacological agents that can protect, repair and regenerate the early damage produced in cells and tissues by ionizing radiation. Protection depends on the ability of chemical agents to reduce the intracellular concentration of free radicals and reactive oxygen species that are produced within the first millisecond after irradiation. The first-generation chemical agents used as radioprotectants are compounds with antioxidant and scavenging potential. Various novel compounds are currently under clinical investigation as radioprotectants that can accelerate recovery of tissue stem cells and their precursors after radiation exposure. Current treatment strategies also include the use of immunomodulators and natural products with free radical-scavenging capability and the ability to induce bone morrow recovery.

UR - http://www.scopus.com/inward/record.url?scp=59349096953&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59349096953&partnerID=8YFLogxK

U2 - 10.1358/dof.2008.033.08.1231875

DO - 10.1358/dof.2008.033.08.1231875

M3 - Review article

VL - 33

SP - 681

EP - 689

JO - Drugs of the Future

JF - Drugs of the Future

SN - 0377-8282

IS - 8

ER -